COPD

Unreported exacerbations of chronic obstructive pulmonary disease (COPD) in clinical trials may be more prevalent than researchers realize, and this could cause them to underestimate the frequency of clinically significant exacerbations. This could affect the conclusions studies reach about the effectiveness of treatments.

Researchers examined risk factors that could lead to frequent physical or mental stress in Americans with chronic obstructive pulmonary disease (COPD).

In a review of revefenacin, researchers found that the drug may have the potential to serve as long-acting bronchodilator for once-daily treatment of respiratory disorders such as chronic obstructive pulmonary disease (COPD).

Among veterans admitted to the hospital for chronic obstructive pulmonary disease (COPD) exacerbation, women were evaluated and treated differently than men prior to hospitalization and had better hospital-associated outcomes.

A new study has found that prevalence rates of chronic obstructive pulmonary disease varied by occupation.

Changing patients from an inhaled corticosteroid (ICS)/long-acting β agonist (LABA) inhaler and long-acting muscarinic agonist (LAMA) inhaler to a LAMA/LABA inhaler and a separate ICS inhaler did not appear to affect patient-reported chronic obstructive pulmonary disease (COPD) symptom scores.

Diabetes is associated with an increased risk of death in patients with chronic obstructive pulmonary disease (COPD), but use of metformin can mitigate and even reverse this risk, according to a new study.

E-cigarettes have become increasingly popular in the United States since their introduction in 2007. Reported use has dramatically increased among adults and, alarmingly, youths, as well. Sales of e-cigarettes, other vaping devices, and e-liquids have increased nearly 1400% over the last decade.

Insurance status was found to potentially affect whether patients who used emergency department services were transferred to other hospitals, discharged, or admitted to hospitals.

By providing case management, self-management education, and skills training, integrated disease management is associated with fewer exacerbations and improved quality of life (QOL) among patients with chronic obstructive pulmonary disease (COPD) enagaged in primary care.

Individuals with an obstructive lung disease saw improvement in lung function when they replaced 30 minutes of sedentary time per day with strenuous or strength-building physical activity.

A review of studies assessing the impact of telemonitoring on chronic obstructive pulmonary disease (COPD) outcomes resulted in mixed findings.

Patients with chronic obstructive pulmonary disease (COPD) had lower medication adherence when taking 3 inhalers compared with 2, suggesting that reducing the number of inhalers for these patients may improve adherence.

Symptoms of dyspnea in a patient with chronic obstructive pulmonary disease (COPD), which were caused by pulmonary hyperinflation, were improved by endobronchial valve treatment.

Based on dehydroepiandrosterone and growth hormone levels, researchers have determined that chronic obstructive pulmonary disease (COPD) is associated with increased biological age.

Exposure to dust from the collapse of the World Trade Center has been associated with a multitude of respiratory outcomes. For the first time, researchers looked at how dwellings in Lower Manhattan were damaged, how they were repaired, how people cleaned up afterwards, and how these differences affected the likelihood of respiratory symptoms and diseases.

Those who use e-cigarettes face higher risks of having a heart attack, experiencing emotional distress, and developing coronary artery disease compared to non-users, according to an abstract to be presented at the upcoming American College of Cardiology Scientific Sessions and Exposition in New Orleans, Louisiana.

Analysis of a 2-year study showed that fluctuations in yearly chronic obstructive pulmonary disease (COPD) exacerbation rates may be associated with variations in Haemophilus influenzae colonization.

A recent study measured exhaled breath condensate (EBC) content that contained ultrafine particles (UFP) as a reflection of inflammation and oxidative stress in patients with chronic obstructive pulmonary disease (COPD) and as a marker of exacerbations.

The vast majority of patients with COPD require greater motivation to seek help when symptom changes occur and are unaware of their increased risk of developing lung cancer, according to new research.

There is no significant evidence to suggest that acute exacerbations of chronic obstructive pulmonary disease (COPD) cause an overall decline in patients’ physical activity over time, according to a new longitudinal study.

Researchers examined the medical costs for patients with a rare subset of chronic obstructive pulmonary disease (COPD) caused by a deficiency in alpha-1 antitrypsin receiving augmentation therapy.

A UK study found that adding respiratory health screenings to drug clinic appointments for those trying to recover from heroin use was effective at uncovering chronic obstructive pulmonary disease (COPD) in this group of patients.

There is not enough evidence that manual therapy—a clinical approach of using skilled, physical, hands-on procedures to improve function, lessen pain, and facilitate movement—can successfully be used to treat chronic obstructive pulmonary disease (COPD).

A survey of patients with chronic obstructive pulmonary disease (COPD) who had contracted community-acquired pneumonia showed that the additional illness caused a significant burden, such as lost time from work, as well as a burden on their caregivers.

Six areas that need improvement emerged from a workshop examining best practices and models to reduce hospital readmissions in patients with chronic obstructive pulmonary disease (COPD).

A recent review showed that the long-term use of statins reduced the risk of acute exacerbation in chronic obstructive pulmonary disease (COPD), heart disease–related mortality and all-cause mortality, as well as decreased inflammatory factors.

Asthma–COPD overlap (ACO) is a term that encompasses patients with characteristics of 2 conditions, asthma and chronic obstructive pulmonary disease (COPD). A recent study from Spain sought to validate a proposed algorithm to help clinicians identify ACO among patients with COPD, in an effort to tailor treatment.

A phase 4 study of formoterol fumarate showed similar safety performance as placebo in patients with moderate-to-severe chronic obstructive pulmonary disease, according to a recently published study.

Researchers in the United Kingdom used a Markov microsimulation model comparing a population with chronic obstructive pulmonary disease (COPD) performing physical activity vs a COPD population that was sedentary, in order to estimate the cost-effectiveness of regular PA vs a sedentary lifestyle.